详情页 - 首都医科大学宣武医院知识库

资源类型：

文章类型：

作者：

Bastiaan R Bloem[1] * ; Emily J Henderson[2,3] ; E Ray Dorsey[4] ; Michael S Okun[5] ; Njideka Okubadejo[6] ; Piu Chan[7]

; John Andrejack[8] ; Sirwan K L Darweesh[1] ; Marten Munneke[1] ;

机构： [1]Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Centre of Expertise for Parkinson and Movement Disorders, Radboud University Medical Centre, Nijmegen, Netherlands [2]Older People’s Unit, Royal United Hospitals Bath NHS Foundation Trust, Bath, UK [3]Department of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK [4]Centre for Health and Technology, Department of Neurology, University of Rochester Medical Centre, Rochester, NY, USA [5]Norman Fixel Institute for Neurological Diseases, Department of Neurology, University of Florida, Gainesville, FL, USA [6]Neurology Unit, Department of Medicine, College of Medicine, University of Lagos, Lagos, Nigeria [7]Department of Neurobiology, Neurology and Geriatrics, National Clinical Research Centre for Geriatric Disorders, Xuanwu Hospital of Capital Medical University, Beijing, China [8]Queens College, City University of New York, NY, USA

出处：

DOI：

ISSN：

基金：

BRB currently serves as co-editor in chief for the Journal of Parkinson's Disease, serves on the editorial board of Practical Neurology and Digital Biomarker. BRB has received honoraria from serving on the scientific advisory board for AbbVie, Biogen, and Union Chimique Belge. BRB has received speaker fees from AbbVie, Zambon, Roche, GE Healthcare, and Bial, and has received grants from the Netherlands Organisation for Scientific Research, Michael J Fox Foundation, Union Chimique Belge, AbbVie, Stichting Parkinson Fonds, Hersenstichting Nederland, Parkinson's Foundation, Verily Life Sciences, Horizon 2020, and Parkinson Vereniging. EJH received funding from the UK National Institute of Health (NIH) Research, the Gatsby Foundation, British Geriatrics Society, and Parkinson's UK. EJH has also received speaker and consultancy fees from Profile, Medicys, and Luye and received travel support from Bial AbbVie and Ever pharma. MSO serves as a consultant for the Parkinson's Foundation, and has received research grants from the US NIH, Parkinson's Foundation, the Michael J Fox Foundation, Parkinson Alliance, Smallwood Foundation, Bachmann-Strauss Foundation, Tourette Syndrome Association, and University of Florida Foundation. MSO's deep brain stimulation research is supported by NIH National Institute of Nursing Research (R01NR014852) and NIH National Institute of Neurological Disorders and Stroke (R01NS096008). MSO has received royalties for publications with Demos, Manson, Amazon, Smashwords, Books4Patients, Perseus, Robert Rose, Oxford, and Cambridge for movement disorder books. MSO is an Associate Editor for New England Journal of Medicine Journal Watch Neurology. MSO has participated in continuing medical education courses and educational activities on movement disorders sponsored by the Academy for Healthcare Learning, PeerView, Prime, QuantiaMD, WebMD–Medscape, Medicus, MedNet, Einstein, MedNet, Henry Stewart, American Academy of Neurology, Movement Disorders Society, and Vanderbilt University. The University of Florida and not MSO receives grants from Medtronic, AbbVie, Abbott, and Allergan. MSO has participated as a site principal investigator or co-investigator for several NIH, foundation, and industry sponsored trials over the years but has not received honoraria. Research projects at MSO's institution, the University of Florida, receive device and drug donations from Medtronic, Abbott, Boston Scientific, and Neuropace. ERD is a medical adviser to and holds stock options in Grand Rounds, which provide a second opinion on the diagnosis and management of health-care conditions of employees generally of large corporations. ERD has also received honoraria for speaking at American Academy of Neurology courses; received compensation for consulting activities from 23andMe, Clintrex, GlaxoSmithKline, Lundbeck, MC10, MedAvante, Medico Legal services, US National Institute of Neurological Disorders and Stroke, Shire, Teva, and UCB; and research support from AMC Health, Burroughs Wellcome Fund, Davis Phinney Foundation, Duke University, GlaxoSmithKline, Great Lakes Neurotechnologies, Greater Rochester Health Foundation, Huntington Study Group, Michael J Fox Foundation, National Science Foundation, Patient-Centered Outcomes Research Institute, Prana Biotechnology, Raptor Pharmaceuticals, Roche, Saffra Foundation, and University of California Irvine. PC has received honoraria from serving on the scientific advisory board for Lundbeck, Teva, and Green Valley. PC has also received speaker fees from Roche, Lundbeck, Sanofi, Eisai, Green Valley, Luye, GlaxoSmithKline, Medtronic, and Boehringer-Ingelheim; and has received research support from Chinese Organisations for Scientific Research, and Michael J Fox Foundation. SKLD has received a research grant from the Parkinson Foundation. MSO, JA, and MM declare no competing interests.

语种：

WOS：

PubmedID：

中科院(CAS)分区：

出版当年[2019]版：

大类 | 1 区

医学

小类 | 1 区临床神经病学

最新[2023]版：

大类 | 1 区

医学

小类 | 1 区临床神经病学

JCR分区：

出版当年[2018]版：

Q1 CLINICAL NEUROLOGY

最新[2023]版：

Q1 CLINICAL NEUROLOGY

第一作者：

第一作者机构： [1]Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Centre of Expertise for Parkinson and Movement Disorders, Radboud University Medical Centre, Nijmegen, Netherlands

通讯作者：

推荐引用方式(GB/T 7714)：

APA：

MLA：

Patient-centred management of Parkinson's disease – Authors' reply(Open Access)

文献详情